Power of Story
Send a Tweet        
- Advertisement -

Share on Google Plus Share on Twitter Share on Facebook Share on LinkedIn Share on PInterest Share on Fark! Share on Reddit Share on StumbleUpon Tell A Friend

Printer Friendly Page Save As Favorite View Favorites (# of views)   No comments

Martin Shkreli walks back on pledge to lower price of HIV drug Daraprim

Quicklink submitted By   Follow Me on Twitter     Message Sheila Samples     Permalink
Related Topic(s): ; ; , Add Tags

Must Read 1   Valuable 1  
View Ratings | Rate It

opednews.com Headlined to H4 11/27/15

Become a Fan
  (45 fans)
From youtube.com/watch?v=WVIgveDesEY: Price Gouging Drug CEO Martin Shkreli
Price Gouging Drug CEO Martin Shkreli
(Image by The Young Turks, Channel: TheYoungTurks)
  Permission   Details   DMCA

Controversial pharmaceutical boss Martin Shkreli has has decided he’s not going to lower the price of his HIV medication after all. Shkreli’s company Turing Pharmaceuticals announced on Wednesday that it would provide volume discounts of its drug Daraprim to hospitals, but it appears that the company’s $750-a-pill price tag still stands. Turing and Shkreli attracted a firestorm of criticism in September after it was revealed the company had raised the price of Daraprim, a 62-year-old treatment for parasitic infections, to $750 a pill from $13.50 after acquiring it. The medicine once sold for $1 a pill.

Read the rest of the story HERE:

At www.theguardian.com

- Advertisement -
- Advertisement -